Can Hemophilic Patients Be Adequately Maintained with Cryoprecipitates? Or Is it Desirable or Even Necessary to Manufacture and Administer Highly Concentrated AHF Products?
- 1 June 1972
- journal article
- Published by Wiley in Vox Sanguinis
- Vol. 22 (6) , 554-565
- https://doi.org/10.1111/j.1423-0410.1972.tb04646.x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The Prophylactic Approach to Hemophilia AHospital Practice, 1971
- Home Transfusion for Patients with Hemophilia ANew England Journal of Medicine, 1970
- Antihemophilic Factor VIII in HemophiliaJAMA, 1970
- Reaction to Rapidly Infused AHF CryoprecipitateNew England Journal of Medicine, 1969
- Fractions Rich in Factor VIIIPublished by S. Karger AG ,1967
- Biological Half-Life of Transfused Antihaemophilic Globulin (Factor VIII) In Normal ManBritish Journal of Haematology, 1967
- A Method for Preparing Plasma Factor VIII (Antihemophilic Globulin) ConcentrateAmerican Journal of Clinical Pathology, 1966
- Clinical Use of Cold Precipitated Antihemophilic Globulin (Factor VIII, CPAG)Transfusion, 1965
- Haemophilia in Sweden VII. Incidence, Treatment and Prophylaxis of Arthropathy and other Musculo-Skeletal Manifestations of Haemophilia A and BActa Orthopaedica, 1965
- A CONCENTRATE OF HUMAN ANTIHÆMOPHILIC FACTOR: ITS USE IN SIX CASES OF HÆMOPHILIAThe Lancet, 1957